Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Medeor Therapeutics
1875 South Grant Street, Suite 130
San Mateo, CA 94402
Phone: 650-627-4531
http://www.medeortherapeutics.com/

Medeor Therapeutics is a clinical-stage biotechnology company dedicated to the discovery, development and commercialization of personalized cellular immunotherapies to improve outcomes in organ transplant recipients. Medeor's series of product candidates each comprise a unique composition of different types of hematopoietic organ donor-derived cells, based on breakthrough technologies discovered at Stanford University and exclusively licensed by Medeor. These product candidates are designed to produce mixed chimerism, the co-existence of both recipient and donor blood and immune cells in the recipient, to achieve donor-specific immune tolerance, to prevent transplant organ loss, to reduce or eliminate chronic immunosuppressive drug therapy, and thereby to improve patient outcomes.

Key Contact
Name
Steven Deitcher
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
11/27/17 $57,000,000 Series B 6 Dimensions Capital
RA Capital Management
Sofinnova Ventures
Vivo Capital
WuXi Healthcare Ventures
undisclosed